Regulation of Apo-2 ligand/trail expression in NK cells - Involvement in NK cell-mediated cytotoxicity

被引:70
|
作者
Johnsen, AC [1 ]
Haux, J
Steinkjer, B
Nonstad, U
Egeberg, K
Sundan, A
Ashkenazi, A
Espevik, T
机构
[1] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Biol, N-7005 Trondheim, Norway
[2] Genentech Inc, Dept Mol Oncol, S San Francisco, CA 94080 USA
关键词
Apo-2; ligand; TRAIL; NK; cytotoxicity; apoptosis;
D O I
10.1006/cyto.1999.0489
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apo-2L is a new member of the tumour necrosis factor (TNF) family shown to induce apoptosis in a number of tumour cell lines. Apo-2L mRNA is expressed by numerous human tissues, Here we report that Apo-2L is expressed and utilized by human Natural Killer (NK) cells. NK cells were shown to express surface Apo-2L in response to interleukin 2 (IL-2) activation, and this response was restricted to the CD3(-) population of the NK cells. Apo-2L mRNA and intracellular Apo-2L were present in both CD3(-) and CD3(+) NK cells; however, increased expression in response to IL-2 was only observed in CD3(-) CD56(+) cells. Also, IL-2-activated NK cells were shown to utilize membrane-bound Apo-2L in mediating lysis of Jurkat cells. Furthermore, Apo-2L-induced apoptosis of Jurkat cells was more rapid than Fast-induced apoptosis, indicating an important and distinct role for Apo-22, in apoptotic cell destruction. In conclusion, we report that NK cells express Apo-2L, and that IL-2 activated CD3(-) NK cells utilize the Apo-2L pathway in mediating target cell lysis, (C) 1999 Academic Press.
引用
收藏
页码:664 / 672
页数:9
相关论文
共 50 条
  • [1] Regulation of Fas and Fas-ligand expression in NK cells by cytokines and the involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicity
    Medvedev, AE
    Johnsen, AC
    Haux, J
    Steinkjer, B
    Egeberg, K
    Lynch, DH
    Sundan, A
    Espevik, T
    CYTOKINE, 1997, 9 (06) : 394 - 404
  • [2] Natural killer (NK) cell-mediated cytotoxicity: Differential use of TRAIL and Fas ligand by immature and mature primary human NK cells
    Zamai, L
    Ahmad, M
    Bennett, IM
    Azzoni, L
    Alnemri, ES
    Perussia, B
    JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (12): : 2375 - 2380
  • [3] Regulation of perforin-independent NK cell-mediated cytotoxicity
    Wallin, RPA
    Screpanti, V
    Michaëlsson, J
    Grandien, A
    Ljunggren, HG
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (10) : 2727 - 2735
  • [4] Augmentation of NK cell-mediated cytotoxicity to tumor cells by inhibitory NK cell receptor blockers
    Tajima, K
    Matsumoto, N
    Ohmori, K
    Wada, H
    Ito, M
    Suzuki, K
    Yamamoto, K
    INTERNATIONAL IMMUNOLOGY, 2004, 16 (03) : 385 - 393
  • [5] Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis
    Eischen, CM
    Schilling, JD
    Lynch, DH
    Krammer, PH
    Leibson, PJ
    JOURNAL OF IMMUNOLOGY, 1996, 156 (08): : 2693 - 2699
  • [6] Ral GTPases Regulate Cell-Mediated Cytotoxicity in NK Cells
    Sanchez-Ruiz, Jesus
    Mejias, Raquel
    Garcia-Belando, Maria
    Barber, Domingo F.
    Gonzalez-Garcia, Ana
    JOURNAL OF IMMUNOLOGY, 2011, 187 (05): : 2433 - 2441
  • [7] METHODS FOR ASSESSING NK CELL-MEDIATED CYTOTOXICITY
    Thibault, Gilles
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2009, 76B (06) : 419 - 420
  • [8] Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells
    Mariani, SM
    Krammer, PH
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1998, 28 (05) : 1492 - 1498
  • [9] INHIBITION OF NK CELL-MEDIATED CYTOTOXICITY BY OXYSTEROLS
    KUCUK, O
    STONERPICKING, J
    YACHNIN, S
    GORDON, LI
    WILLIAMS, RM
    LIS, LJ
    WESTERMAN, MP
    CELLULAR IMMUNOLOGY, 1992, 139 (02) : 541 - 549
  • [10] DEFECTIVE NATURAL-KILLER (NK) CELL-MEDIATED CYTOTOXICITY DOES NOT IMPLY CLONAL INVOLVEMENT OF NK CELLS IN MYELODYSPLASTIC SYNDROMES
    OGATA, K
    FUJII, H
    YOKOSE, N
    AN, E
    TAMURA, H
    KAMIKUBO, K
    DAN, K
    HAMAGUCHI, H
    SAKAMAKI, H
    ONOZAWA, Y
    NOMURA, T
    BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (02) : 396 - 398